接头 CAR 共表达在淋巴瘤单一及双重抗原丢失后保留 CAR-T 细胞疗效 Co-expression of an adapter CAR retains efficacy of CAR T cells after single and dual antigen loss in lymphoma. PubMed 2025/10/24 发表Mol TherQ1 · IF 11.4(JCR 2025) 靶点:CD19靶点:CD20靶点:ROR1技术:CAR-T技术:双特异性抗体淋巴瘤 72.6分 ★★★★☆ 站内排序·非疗效